Trials / Sponsors / Eureka Therapeutics Inc.
Eureka Therapeutics Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Neoplasms | Phase 1 / Phase 2 | 2022-07-19 |
| Recruiting | T-Cell Therapy (ECT204) in Adults With Advanced HCC Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm | Phase 1 / Phase 2 | 2022-03-11 |
| Terminated | Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) Hepatocellular Carcinoma, Liver Cancer, Liver Neoplasm | Phase 1 | 2021-04-14 |
| Terminated | Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma, Liver Cancer, Liver Neoplasm | Phase 1 | 2019-05-30 |
| Terminated | Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma Lymphomas Non-Hodgkin's B-Cell | Phase 1 | 2018-04-04 |
| Completed | Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma Lymphoma, B-Cell | Phase 1 | 2017-09-09 |